Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma Meeting Abstract
| Authors: | Slingluff, C. L.; Zarour, H. M.; Postow, M. A.; Friedlander, P. A.; Devoe, C. E.; Smith, K.; Deacon, D.; Macri, M. J.; Ryan, A.; Venhaus, R. R.; Wolchok, J. D. |
| Abstract Title: | Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Language: | English |
| ACCESSION: | WOS:000442916004746 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.e15175 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e15175 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work